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1058-9813/© 2016 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oAvailable online 18 August 2016 Congenital heart disease is associatedwith abnormal ventricular shape that can affectwallmechanics andmay be
predictive of long-term adverse outcomes. Atlas-based parametric shape analysiswas used to analyze ventricular
geometries of eight adolescent or adult single-ventricle CHD patients with tricuspid atresia and Fontans. These
patients were compared with an “atlas” of non-congenital asymptomatic volunteers, resulting in a set of Z-
scores which quantify deviations from the control population distribution on a patient-by-patient basis. We ex-
amined the potential of these scores to: (1) quantify abnormalities of ventricular geometry in single ventricle
physiologies relative to the normal population; (2) comprehensively quantify wall motion in CHD patients;
and (3) identify possible relationships between ventricular shape and wall motion that may reﬂect underlying
functional defects or remodeling in CHD patients. CHD ventricular geometries at end-diastole and end-systole
were individually compared with statistical shape properties of an asymptomatic population from the Cardiac
Atlas Project. Shape analysis-derived model properties, and myocardial wall motions between end-diastole
and end-systole, were compared with physician observations of clinical functional parameters. Relationships be-
tween altered shape and altered function were evaluated via correlations between atlas-based shape and wall
motion scores. Atlas-based shape analysis identiﬁed a diverse set of speciﬁc quantiﬁable abnormalities in ventric-
ular geometry or myocardial wall motion in all subjects. Moreover, this initial cohort displayed signiﬁcant rela-
tionships between speciﬁc shape abnormalities such as increased ventricular sphericity and functional defects
inmyocardial deformation, such as decreased long-axiswallmotion. Theseﬁndings suggest that atlas-based ven-
tricular shape analysis may be a useful new tool in the management of patients with CHDwho are at risk of im-
paired ventricular wall mechanics and chamber remodeling.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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CHD1. Introduction
Cardiac malformations are the most common type of birth defect,
occurring in approximately 1% of all births. Improvements in the man-
agement of congenital heart disease (CHD) have resulted in N90% of
those born with CHD now surviving into early adulthood [2,3,11].
Many of these patients, particularly those with a single functional
ventricle, are at risk of ventricular remodeling and dysfunction withand AAY and 8P41GM103426
iversity of California San Diego,
).
land Ltd. This is an open access articlassociatedmorbidity andmortality [2,17]. Heart failure (HF) is common
in these patients and often develops overmany years [15], but relatively
little detail is known about the ventricular remodeling characteristics
leading to heart failure in CHD. CHD patients commonly undergo longi-
tudinal cardiac magnetic resonance imaging (cMRI) exams; however,
standard clinical indices of mass, volume, diameter and wall thickness
ignore the wealth of additional information in cMRI data regarding the
more subtle or regional abnormalities in ventricular shape andwallmo-
tion that are common in these cardiac malformations.
Atlas-based shape analysis of cMRI data has shownpromising results
for quantifying alterations in ventricular shape in other heart diseases
[13–15,17–19]. A model-based analysis of right ventricular (RV) shape
identiﬁed increased eccentricity and decreased systolic function in pa-
tients with pulmonary hypertension [8]. A statistical shape analysis ine under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Quantitative clinical patient data. BSA=body surface area, HR=heart rate, LV EDV= left
ventricular end diastolic volume, LVEF = left ventricular ejection fraction, LV Mass = left
ventricularmass. aIndicates the value is N1 standard deviation above the normalmean [1].
Patient Age
range
LV EDV
(cc)
LV EDV indexed
to BSA (cc/m2)
LVEF
(%)
LV mass
(g)
LV mass indexed
to BSA (g/m2)
1 17–25 175 109a 52 131 82a
2 35–45 124 65 65 125 65
3 13–16 124 77 55 112 70
4 17–25 238 124a 55 150 78
5 17–25 137 77 57 83 52
6 17–25 197 89 62 143 65
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of RV dilatation, outﬂow tract bulging, and apical dilatation with the
presence of pulmonary regurgitation [9]. A study of shape analysis in
myocardial infarction showed that atlas-based shape parameters classi-
ﬁed patients from asymptomatic controls with 94% speciﬁcity and 93%
sensitivity [12,14]. An MRI study using the same type of shape analysis
techniques showed that young adults born pre-term had signiﬁcant dif-
ferences in LV mass, 3D geometry and regional wall motion that could
predispose them to heart disease in later life [10].
Atlas-based cardiac shape analysismay be particularly useful for sin-
gle ventricle CHD as current methods are suboptimal for assessment of
remodeling and heart failure risk for these unique patients.
Eight adolescent or adult patients with tricuspid atresia and
Fontan physiology were recruited for this study of shape analysis in
single ventricle physiology. The three goals of this study were to:
evaluate whether atlas-based shape analysis could detect and quan-
tify relevant abnormalities in ventricular geometry in eight tricuspid
atresia patients; to test a novel atlas-based assessment of ventricular
function derived from shape deformations between end-diastole and
end-systole; and to assess potential relationships between abnormal
ventricular shape and abnormal in ventricular function in the CHD
patients.
2. Materials and Methods
2.1. CHD MR Imaging Data
The datasets used in this study are part of the Cardiac Atlas Project
(CAP) database⁎. The CAP was established as a worldwide consortium
for pooling standardized analyses of cardiac images into a database for
mapping heart shape and motion [5,12,14]. Cardiac MR datasets were
obtained with informed consent compatible with data sharing, and data
were contributed to the CAP databasewith the approval of the local insti-
tutional review board. The general selection criteria for this preliminary
study were: (1) a diagnosis of tricuspid atresia and hypoplastic right
ventricle, (2) Fontan physiology, and (3) the patient being of adult size.
Standardized procedures for the contribution, de-identiﬁcation, classiﬁ-
cation, and sharing of imaging data were provided by CAP. In addition,
relevant demographic and clinical data were obtained for each patient,
including age, diagnoses, co-morbidities, medications, cardiac catheteri-
zation reports and echocardiography. All imaging and clinical data were
de-identiﬁed in a HIPAA-compliant manner. Eight adult or teen-aged pa-
tients meeting these criteria were included in this study.
For patients 1 to 5, SSFP (Steady State Free Precession) cine images
were obtained on a 1.5 T (Tesla) Philips Intera MRI scanner (Philips
Medical Systems, Netherlands) using a 5-element cardiac coil using
breath-holds and retrospective gating. The sequence parameters for
SSFP sequence were: repetition time (TR) 2.7 ms, echo time (TE)
1.36 ms, ﬂip angle 60 degrees, ﬁeld of view (FOV) 400 mm, slice thick-
ness 8 mm, image matrix 192 × 256 and 30 heart phases.
For patients 6 to 8, images were acquired using a 1.5 T MRI scanner
(Siemens Avanto; Siemens Healthcare, Erlangen, Germany) and all
cines were prospectively or retrospectively gated breath-hold SSFP ac-
quisitions. The short axis slices were acquired parallel to the tricuspid
annulus plane and spanned both ventricles. Long axis slices were ob-
tained through all valves and spanning both ventricles. The standard
images parameters were as follows: slice thickness 6 mm, ﬂip angle
60 degrees, TE 1.6 ms and TR 30 ms.
2.2. Clinical Data and Physician Observations
Clinical data were collected for each patient. Quantitative measure-
ments from the images including end-diastolic volume (EDV), stroke⁎ http://www.cardiacatlas.org.volume (SV), ejection fraction (EF), and left ventricular mass (LVM)
were made using QMass Medis software, Leiden, The Netherlands. Vol-
ume for each image plane is calculated as the area of the endocardial
tracing multiplied by the addition of the image slice thickness and
inter-slice gap. End-diastolic and-systolic volumes are calculated by
summing all slices, which allows for calculation of stroke volume, cardi-
ac output, and ejection fraction with standard equations [1], and are
summarized in Table 1. Physician assessments of hypertrophy, dilation,
and systolic dysfunction based on clinical history and reading of theMR
images are summarized in Table 2 alongwith individual patient surgical
history and additional observations. For the purposes of comparing
patient data in this study, mild hypertrophy and mild dilation were
deﬁned by LV EDV and LV mass, respectively, indexed to body sur-
face area, greater than one standard deviation greater than the mean
for normal ventricles [1]. Decreased LV systolic function was deﬁned
as EF b 0.55.
2.3. Model Customization for CHD Data
Expert observers performed the geometric ﬁt analysis with
guide-point modeling [20] using custom software (CIM, University
of Auckland, New Zealand) to create 3D ventricular anatomic models
for each CHD patient based on the MR datasets. The model was inter-
actively customized by least-squares optimization to guide points
provided by the analyst, as well as computer-generated points cal-
culated from the image using an edge detection algorithm. The
model was registered to each case using ﬁducial landmarks deﬁned
at the mitral valve and the insertions of the right ventricular free
wall into the inter-ventricular septum. Fig. 1 shows a screenshot
of model customization of patient MRI data using CIM.
The LV shapemodel consisted of 16 elements per LV surface, for both
the endocardium and the epicardium. Surface points were sampled
using 8 × 8 grid points per element, resulting in a total of 1682 unique
3D coordinate points for both endocardial and epicardial surfaces. A
prolate spheroidal coordinate systemwas used to deﬁne a standardized
coordinate system of the LV for each patient, registered to ﬁducial land-
marks including the inﬂow valve insertion points, and apical and basal
landmarks, in order to remove variations in position and orientation
between cases.
2.4. Statistical (Population) Properties of Asymptomatic Ventricles
This study made use of previously described [13] shape models de-
rived from cardiac MR exams of 1991 asymptomatic subjects in the
CAP database. These were participants who were free from any clinical
indications of cardiovascular disease at time of imaging, and were thus
considered as a normal control group. In previously reported results,
principal component analysis (PCA) was used to determine the domi-
nant modes of LV shape variation in this population for both end-
diastolic and end-systolic states recorded in the MR images. These sta-
tistical shape properties [13] were used for the ﬁrst goal of this study:
assessment of abnormalities in CHD ventricular shapes.7 17–25 137 87 55 78 50
8 35–45 172 103a 59 102 61
Table 2
Qualitative clinical patient data including physician observations.
Patient LV hypertrophy LV dilation Systolic function Surgeries Other observations
1 No Mild Mildly diminished Fontan, fenestration creation Restrictive valve motion
2 No No Normal Fontan (RA to MPA-LPA, SVC to RPA) Mildly dilated ascending aorta
3 No No Low-normal Damus and arch reconstruction, hemi-Fontan and Fontan Transposed great arteries, restrictive VSD
4 No Moderate Low-normal Lateral tunnel Fontan and transcatheter closure of
Fontan fenestration
Mild mitral and aortic regurgitation,
dilated aortic root
5 No No Normal Fontan, Fontan stent Transposed great arteries, small VSD
6 No No Normal Total cavo-pulmonary connection (TCPC) Fontan
7 No No Low-normal Total cavo-pulmonary connection (TCPC) Fontan
8 No Borderline Normal Atrio-pulmonary Fontan
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ventricularwallmotions, itwasnecessary to obtain statistical properties
of the wall motions for the control group. Below is a brief summary of
the method used to obtain the statistical shape properties for both the
shapes (previously reported) and thewallmotions (novel to the current
study) for the asymptomatic population.
PCA has been used to extractmodes of LV deformation [16], to quan-
tify cardiac remodeling [10,21], and to identifymodes of shape variation
within a sub-clinical population [13]. To obtain the population statistics
used here, the total inputmatrix size for the PCAwas 1991 × 5046. That
is, 1991 datasets in the asymptomatic control group, and 1682 coordi-
nate points formatted in a row vector [x1,y1,z1,… ,xM,yM,zM], where
M = 1682 (and 3 × M = 5046). We used three PCA models in this
study, built from the LV shapes at (1) end-diastole (PCAED), (2) end-
systole (PCAES), and (3) the wall motion between ED and ES frames
(PCAWM). For the PCAWM model, the input matrix is simply a subtrac-
tion of the surface coordinate points at ES from the corresponding coor-
dinate points at ED. Hence, instead of variations in point locations (as in
PCAED and PCAES) the PCAWM model describes variations of the dis-
placement vectors.Fig. 1.Modeling tool for atlas-based venThe PCA procedure is described brieﬂy as follows. Let X be the input
matrix and X ¼ 1
N
∑Xi be the estimated mean shape (N=1991), prin-
cipal components were computed using singular value decomposition
(SVD) on the standardized ðX−XÞ matrix. In the context of statistical
shape analysis, the k-th mode of shape variation can be generated by
selecting only the k-th principal component to reconstruct a shape, or.
yk ¼ X þΦδek
whereΦ∈R3Mx3M is the principal component matrix, ek is a zero vector
except the k-th component is 1, and δ is the distance of the shape vari-
ation from the mean. A statistically plausible shape is commonly set for
δ between ±2 times the standard deviation of the k-th eigenvalue. The
ﬁrst few modes characterize the dominant shape variations in the
data and explain most of the shape variance in the population.
These variations in shape have been related to certain types of ven-
tricular remodeling.
Generally, the ﬁrst few modes explain most of the total popu-
lation variance in previous studies of ventricular shape analysistricular shape modeling using cMRI.
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three PCA models. For PCAED, the percentages of shape variation
explained by the ﬁrst ﬁve modes were: 44%, 11%, 9%, 7%, 5%.
Therefore, the ﬁrst ﬁve modes explain 76% of the total variation in
ED shapes in the asymptomatic population. For PCAES, the percent-
ages of shape variation explained by the ﬁrst ﬁve modes were: 43%,
11%, 7%, 5%, 4%. Therefore, the ﬁrst ﬁve modes explain 71% of the
total variation in ES shapes in the asymptomatic population. Further-
more, the ﬁrst ﬁve modes have visually notable features and the pur-
pose of this initial study was to assess shape and wall motion scores
for the modes that could also be related to physician observations.
The previously reported [13] geometric manifestations of the ﬁrst
ﬁve statistical modes of shape variation in the population of asymptom-
atic controls are shown in Fig. 2 for the ED shape and in Fig. 3 for ES
shape for reference. For each mode, the mean shape is juxtaposed
with the +2σ and –2σ shape. Note that ED mode 1 is primarily domi-
nated by variations in LV size, with the –2σ shape being signiﬁcantly
larger and the +2σ shape signiﬁcantly smaller than the mean. The
second and third modes appear to be dominated by differences inModes -2SD
1
2
3
4
5
Fig. 2. The ﬁrst ﬁve modes of asymptomatic shape variation at ED. Mean,−2SD, ansphericity and valve plane orientations. Mode four appears to capture
variations in valve orientations. For the ES shapes, LV size also appears
to dominate mode 1, and wall thickness variations appear to dominate
mode 2. Mode 3 appears to be related to sphericity and valve orienta-
tion, and mode 4 captures variations associated with a combination of
wall thickness and tilted valve orientation.
Theﬁrst ﬁvemodes of variation in the ventricularwall motions in the
asymptomatic population [Fig. 4] are described in the results section.
These modes represent different features of regional ventricular wall
motions.
2.5. Calculation of CHD Patient-Speciﬁc Z-scores Relative to Control
Population Data
To gain insight into shape abnormalities in CHD geometries at ED
and ES, as well as functional abnormalities, Z-scores were calculated to
describe how much an individual CHD patient differs from the control
population mean. The following describes the calculation of the
Z-scores for each CHD dataset for PCAED, PCAES and PCAWM.mean +2SD
d +2SD shapes are shown to illustrate the geometric meaning of the modes.
Modes -2SD mean +2SD
1
2
3
4
5
Fig. 3. The ﬁrst ﬁve modes of asymptomatic shape variation at ES. Mean,−2SD, and +2SD shapes are shown to illustrate the geometric meaning of the modes.
65G. Farrar et al. / Progress in Pediatric Cardiology 43 (2016) 61–69Principal scores, bS, were calculated for a patient shape, S, projected
onto the PCA model, Φ, of the control population, relative to the mean
control shape, X, as
bsΦ−1 S−X 
Then, the Z-scores were calculated as follows. The standard devia-
tion of the control principal score distribution for each mode j was
calculated as
σ j ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
N−1ð Þ∑
N
i¼1
∑ bj;i−bj
 2s
where bj ,i andbj are the principal scores and themean of the j-thmode,
respectively. Two times the standard deviation of the control principal
score distribution was deﬁned as the threshold signifying abnormal
shape. The Z-scores for the CHD datasets are reported for the ﬁrst ﬁvemode of variation for PCAED, PCAES and PCAWM. Variations of each
mode were then compared with the patient speciﬁc clinical data.
3. Results
3.1. Analysis of ED and ES Shapes
3.1.1. ED Shape Analysis
The ED shape analysis showed that all but one (Patient 1) of the CHD
patients had at least one ED shape mode that was at least two standard
deviations from the mean of the asymptomatic patients (Z N 2.0)
[Table 3]. For EDmode 1, none of the patients had a Z-score N2, indicat-
ing that ventricular sizes in CHDpatientswere not signiﬁcantly different
from the normal group. For ED mode 2, four patients had Z-scores N2,
suggesting that abnormally increased sphericity may be a common
feature of the CHD patient cohort. The highest Z-score (N6) occurred
in ED mode 3 for patient 3. For ED modes 3, 4, and 5, three patients
had Z-scores N2. Each patient had elevated Z-scores in different
modes, indicating that each patient has a ventricular shape with
Modes -2SD mean +2SD
1
2
3
4
5
Fig. 4. Theﬁrst ﬁvemodes of variation in thewallmotion between EDand ES.Mean,−2SD, and+2SD are shown to illustrate the physicalmeaning of themodes.Modes of variation in the
displacement vectors are illustrated as an LV shape that describes the systolic deformation from the mean ED shape (shown as a gray wireframe).
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from the other CHD patients.
3.1.2. ES Shape Analysis
The ES shape analysis showed that all but one (Patient 5) of the CHD
patients had at least one ES Z-score that was at least two standard devi-
ations from the mean of the asymptomatic hearts [Table 4], again indi-
cating that the shape analysis method is quantifying characteristics of
LV shape that are different from normal hearts. For ES mode 1, none ofTable 3
End-diastolic shape analysis results: Z-score values of CHD patient shapes projected onto
PCAED. Absolute values greater than 2σ are highlighted in bold.
Patient ED mode 1 ED mode 2 ED mode 3 ED mode 4 ED mode 5
1 –0.9 0.6 1.3 –1.5 –0.4
2 1.6 3.1 1.4 –3.1 –2.0
3 –0.7 1.6 –6.6 –1.6 –1.5
4 –0.7 2.9 –0.7 –3.5 –1.8
5 1.7 0.8 2.3 –0.6 –0.5
6 0.9 4.5 –0.7 –2.8 –4.8
7 1.3 3.4 –1.2 –1.8 –1.4
8 1.9 1.5 3.4 –0.7 –2.3the patients had a Z-score N2, again indicating that ventricular sizes in
these adult CHD patients were not signiﬁcantly different from normal.
For ES mode 2, only patient 3 had an abnormal Z-score. For ES mode 3,
ﬁve of the patients had Z-scores N2, indicating that abnormally in-
creased end-systolic sphericity is also a feature common to a signiﬁcant
fraction of the CHD patient cohort. For ES mode 4, two patients had
Z-scores N+2, indicating increased wall thickness, and two patients
had scores b−2, indicating decreased wall thickness. Therefore ab-
normalities in end-systolic wall thickness features were present inTable 4
End-systolic shape analysis results: Z-score values of CHD patient shapes projected onto
PCAES. Absolute values greater than 2σ are highlighted in bold.
Patient ES mode 1 ES mode 2 ES mode 3 ES mode 4 ES mode 5
1 –1.3 –1.2 –0.2 –3.4 1.3
2 0.4 –1.8 –2.7 –1.3 1.2
3 –0.8 3.3 –0.8 2.9 4.2
5 –0.2 –1.8 –3.0 0.4 0.7
6 0.7 –1.2 –1.2 –1.0 0.8
7 0.2 1.4 –2.1 2.0 –1.9
8 1.4 1.3 –2.0 0.4 –0.5
9 1.0 –0.7 –2.1 –2.8 –2.3
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again indicating abnormal systolic wall thickness and valve orienta-
tion. Each patient had elevated Z-scores in different modes, indicat-
ing that each patient has a shape that is both different from normal
and different from the other CHD patients.
3.1.3. Patient Speciﬁc Comparison of Shape Z-scores with Physician
Observations
Patient 1 had a Z-score of b−3σ in ESmode 4, which is associatedwith
mitral valve orientation. This featuremay be related to the re-
strictive valve motion observed in this patient. A low score in
ESmode4 is associatedwith decreased LVwall thickness. This
might be consistent with the physician observation of mild
dilation.
Patient 2 showed N2σ values for ED modes 2 and 4, and ES mode 3. All
three of these modes are associated with altered valve orien-
tation. The negative value in ESmode 4 and the positive value
in ED mode 2 are indicative of increased sphericity.
Patient 3 has an unusual LV shape, which is elongated and slightly
curved around the RV apex. A large negative value in ED
mode 3, indicative of decreased sphericity, makes sense
given the elongated shape.
Patient 4 had physician observations of mild mitral and aortic regurgi-
tation and a dilated aortic root. This patient had a low Z-score
in ED mode 4 and ES mode 3, which are indicative of altered
valve orientation and may reﬂect effects of the altered anato-
my observed at the base of the LV. The clinical observations
also included moderate LV dilation. This patient had high ED
mode 2 and low ESmode 3, which are indicative of an abnor-
mally spherical LV shape.
Patient 5 had a score of N2σ in ED mode 3, which is associated with in-
creased sphericity and abnormal valve orientation.
Patient 6 had a high score N4σ in ED mode 2, indicative of increased
sphericity, low N2σ ED mode 4 indicative of altered valve
orientation, and low N2σ ES mode 3 indicating increased
sphericity and 4 decreased wall thickness. However, this pa-
tient had no observed dilation and normal systolic function.
Patient 7 had high N3σ ED mode 2, indicative of increased sphericity,
and low N2σ ES mode 2 indicating increased wall thickness
and ES mode 3 indicating increased sphericity. This patient
had no hypertrophy or dilation and normal systolic function.
Patient 8 had a high score (N3) in EDmode 3, and a low score (b−2) in
ES mode 3, both indicating increased sphericity. A low score
(Z b−2) in ES mode 4 suggested decreased wall thickness
and altered valve orientation. This patient had no observation
of dilation and had normal systolic function.Table 5
Wall motion analysis results: Z-score values of CHD patient shapes projected onto PCAWM.
Absolute values greater than 2σ are highlighted in bold.
Patient Disp mode 1 Disp mode 2 Disp mode 3 Disp mode 4 Disp mode 5
1 –1.1 1.4 –1.7 –2.4 3.1
2 –1.4 2.5 –2.2 –1.7 2.8
3 0.5 1.8 –0.4 –2.2 4.3
5 –0.4 –0.1 0.4 –1.1 4.8
6 –0.9 2.3 –2.6 –1.1 2.5
7 –0.4 3.1 –1.8 –1.5 2.8
8 –0.5 1.2 –0.2 –1.7 3.3
9 –0.5 2.1 –2.1 –1.1 3.23.2. Analysis of Wall Motions
3.2.1. Modes of Variation in Wall Motion for the Asymptomatic Population
Geometric renderings of the ﬁrst ﬁve systolic wall motion modes
(PCAWM) for the asymptomatic population are shown superimposed
on the mean ED shape in Fig. 4. Mode 1 is dominated by longitudinal
shortening, including vertical base-plane movement. Mode 2 is also as-
sociated with longitudinal movement, but more prominently at the
apex, and includes variations in apical wall thickening. Mode 3 captures
variations in base plane displacements in the inferior-posterior plane
and some systolic wall thickening. Mode 4 is mainly associated with
base plane movement in the lateral-septal plane. Mode 5 describes
overall contraction of the ventricle. The percentages of variation in
PCAWM explained by the ﬁrst ﬁve modes were: 21%, 13%, 10%, 8%, 6%.
Therefore, the ﬁrst ﬁve modes explain 58% of the total variation in ven-
tricular wall motion in the asymptomatic population.3.2.2. CHD Wall Motion Z-scores
All CHD patients had at least one Z-score over 2 in magnitude,
indicating that ventricular wall motions were signiﬁcantly different
from normal in some major respect [Table 5]. None of the patients had
Z-scores N2 in Mode 1, but four patients had Z-scores N2 in Mode 2.
Two patients had scores N2 in Mode 3, and three patients had scores
N2 in Mode 4.
Mode 5 showed the highest Z-scores, with all eight CHD patients ex-
ceeding two standard deviations from themean of normal hearts.Mode
5 was associated with global LV contraction. The high Z-scores in mode
5 indicate that the CHD ventricles showed signiﬁcantly less LV contrac-
tion than normal hearts. Thus this score can be compared with global
ejection fraction as a measure of ventricular function. Patients 3, 4,
and 7 had low-normal systolic function (EF = 55%). Patients 3 and 4
had a mode 5 Z-score N 4, and patient 7 had a Z-score N 3. For these pa-
tients, the high Z-scores were a more sensitive index of ventricular dys-
function than EF. The patient with the lowest EF (Patient 1, EF = 52%)
did have an elevated Z-score (N3), but did not have the greatest score.
In apparent contrast, patient 9 had a mode 5 Z-score N 3, but had a nor-
mal EF of 59%. Thus, there was no strong correlation between EF and
wall motion mode 5 (R2 = 0.2); rather, the wall motion Z-scores quan-
tiﬁed more speciﬁc wall motion abnormalities.
3.3. Potential Relationships Between Shape and Wall Motion
In the cohort of eight tricuspid atresia patients, correlations between
shape Z-scores and wall motion Z-scores revealed two interesting ob-
servations. The ﬁrst was a correlation (R2= 0.63) betweenwall motion
mode 1 and EDmode 3.Wall motionmode 1 is associated with longitu-
dinal shortening during systole, and ED mode 3 is associated with LV
sphericity. Therefore, an ED shape thatwasmore spherical tended to co-
incide with a functional difference in which the longitudinal shortening
during systole was reduced.
The second ﬁnding was a correlation (R2 = 0.52) betweenwall mo-
tion mode 5 and ED mode 1. Wall motion mode 5 is associated with
overall LV contraction, and EDmode 1 is associated with LV size. There-
fore, an ED shape that was larger in size tended to coincide with de-
creased ventricular contraction during systole.
4. Discussion
The ED and ES shape analyses showed consistent results. In both
separate analyses, the mode associated with LV size was found to not
show abnormality exceeding the threshold value. Additionally, both
analyses separately showed that sphericity is abnormally increased in
at least half of the CHD patient cohort. The similarity in results between
the ES and ED analyses suggests that the method is indeed consistently
capturing the aspects of altered LV shape relevant in the CHD patients.
Plausible relationships between physician observations and quanti-
tative shape statistics were found in four patients, and relationships be-
tween visually apparent features of ventricular morphology and shape
statistics and were seen in six patients. Thus these quantitative shape
statistics derived from principal components of normal ventricular
68 G. Farrar et al. / Progress in Pediatric Cardiology 43 (2016) 61–69anatomy appear to be capable of quantifying abnormal features of ven-
tricular geometry present in single ventricle CHD patients.
For the wall motion modes, PCAWM, which quantify the statistical
modes of variation in the myocardial deformation of the asymptomatic
hearts between ED and ES, the total variation explained by the ﬁrst ﬁve
modes was less (58%) than that of the shape variations (76% for PCAED
and 71% for PCAES). In future studieswith larger cohorts itmay be useful
to consider a greater number of modes to more fully capture variations
in systolic deformation.
The analysis of systolic deformations showed that all CHD patients
had some abnormal LV contractile function as expected, even though
many of the patients had ejection fractions in the normal range. There
did not appear to be any strong correlations between EF and the wall
motion statistics; hence, this analysis may be quantifying novel aspects
of altered wall motion that are not detected by global volumetric
measurements.
The correlation between a more spherical ED shape and decreased
longitudinal shortening in the deformation is consistent with previous
studies of acquired heart failure and dyssynchrony [18]. More spherical
LV shape has been reported during the progression to HF in animals and
humans [4,6], and decreased systolic ventricular shortening is a well-
known characteristic of the failing heart [18]. The quantitative correla-
tion of these two characteristics in the CHD group suggests there may
be a mechanistic link or that changes in ventricular sphericity and
wall motion mode 5 might be early markers of systolic dysfunction in
single ventricle physiology.
The second correlation, between LV size at ED and contractile func-
tion is also noteworthy. This correlation suggests a relationship between
dilation and decreased systolic function in CHD that may be causal.
Indeed, the patient with the lowest EF also showed mild dilation by
clinical observation. Most patients with single ventricle physiology
also have some component of valvular insufﬁciency that imposes a
volume load and ventricular stretch. These are commonly associated
with right and left HF conditions in CHD [7,19].
The shape analysis approach employed herewas able to identify two
key correlations between shape and function, both of which are broadly
consistent with expectations about the progression of ventricular
remodeling to contractile dysfunction and heart failure. These correla-
tions themselves do not imply causality, but the quantitative three-
dimensional models developed for the shape analysis are also suitable
to develop patient-speciﬁc models of ventricular mechanics that could
test for a mechanistic relationship. Thus, the methods employed in
this study appear to have potential for uncovering more detailed rela-
tionships between shape and function. These relationships could be
used to deﬁne shape parameters as early markers of disease, and
could better inform the assessment of patient risk.
4.1. Limitations
Age-matched asymptomatic population data was not available for
use in this study. The age range of the asymptomatic population was
45–85, whereas the age range of the CHD patients in this study was
13–45. The CAP database is currently being expanded to include more
MR imaging data from a wider age range of both CHD patients and
asymptomatic volunteers. This will enable future studies to compare
CHD patient geometries with age and gender matched sub-cohorts.
Secondly, the number of CHD patients analyzed in this study was
relatively limited. Eight patients were sufﬁcient to achieve the goal of
evaluating the basic utility of the shape analysis approach and develop-
ing new hypotheses. However, this is not large enough for assessing
trends in shape and wall motion characteristics in CHD.
5. Conclusions
The ﬁrst application of atlas-based shape analysis to single ventricle
congenital heart disease reported here shows promise for quantifyingalterations in ventricular geometry that are speciﬁc to congenital heart
disease and may be candidate indicators of adverse ventricular remod-
eling. In particular, abnormalities inmodes of shape variation associated
with ventricular sphericity, ventricular wall thickness, and base plane
orientation were quantiﬁed for the CHD patients. Atlas-based shape
analysis also showed promising results for characterizing alterations
in ventricular wall motion relevant in CHD, as a potentially more
detailed measure of LV function. The wall motion analysis quantiﬁed
aspects of altered systolic function which may not be detectable with
global volume measures such as ejection fraction. Lastly, we showed
that atlas-based shape analysis can identify quantitative relationships
between shape and systolic wall motion. In particular, this study point-
ed toward potential relationships between increased sphericity in ED
shape and decreased longitudinal shortening in the deformation, and
between increased LV size and decreased LV function that should be
tested in larger patient cohorts.
A unique feature of single-ventricle CHD patients is that repeated
MR imaging is common in the clinical setting, spanning years of cardiac
remodeling. Longitudinal studies of the progression of ventricular re-
modeling using atlas-based shape modeling could to lead to more in-
sight into early detection of maladaptive characteristics.
This study pointed toward relationships between LV size (which
could be related to dilation) and function, and between sphericity and
decreased longitudinal shortening. These relationships are likely related
to the physical mechanics of ventricular deformation. Finite element
models of ventricularwallmechanics can be used to test themechanical
basis of relationships between shape and systolic function identiﬁed
with the techniques described here and will reveal new information
about mechanical stress distributions in the single ventricle heart,
which are thought to play a role in adverse remodeling. Biomechanical
parameters could also be correlated with measures of altered shape in
order to discover early markers of patient risk.
Atlas-based shape analysis shows promise for quantifying important
aspects of ventricular shape in CHD, trackingmore detailed patient data
over time, and may eventually lead to improved understanding of pa-
tient risk. The relative speed of creating these models compared with
more conventional segmentation methods makes it feasible for clinical
application, and for creating larger CHD databases in the CAP.
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